Institute of Cell Biology, Histology and Embryology, Center for Molecular Medicine, Medical University of Graz, Austria.
Thromb Res. 2011 Feb;127 Suppl 3:S96-9. doi: 10.1016/S0049-3848(11)70026-3.
Among pregnancy pathologies preeclampsia and fetal growth restriction are among the leading causes of maternal and perinatal mortality and morbidity. For both syndromes, the etiologies are still unclear in many facets. For the development of preeclampsia the presence of the placenta is a prerequisite, while for FGR a variety of other factors may be decisive. Cases with a combination of FGR and preeclampsia are the most severe cases and need clinical intervention. Studies on such cases have misled scientists and clinicians to hypothesize that a failure of trophoblast invasion is a specific feature of the early onset type of preeclampsia. Recent development in preeclampsia specific biomarkers and the intense use of Doppler ultrasound measurements already in the first trimester of pregnancy has resulted in a new understanding of the pathways leading to preeclampsia or FGR.
在妊娠病理中,子痫前期和胎儿生长受限是导致孕产妇和围产儿发病率和死亡率的主要原因之一。对于这两种综合征,其病因在许多方面仍不清楚。对于子痫前期的发展,胎盘的存在是一个前提条件,而对于胎儿生长受限,许多其他因素可能是决定性的。同时患有胎儿生长受限和子痫前期的病例是最严重的病例,需要临床干预。对这些病例的研究误导了科学家和临床医生假设滋养细胞浸润失败是子痫前期早发型的一个特定特征。子痫前期特异性生物标志物的最新进展以及在妊娠早期就大量使用多普勒超声测量,已经导致人们对导致子痫前期或胎儿生长受限的途径有了新的认识。